111 related articles for article (PubMed ID: 23133955)
1. [Molecularly target therapy].
Kiyoi H
Nihon Rinsho; 2012 Apr; 70 Suppl 2():211-6. PubMed ID: 23133955
[No Abstract] [Full Text] [Related]
2. [New agents for solid tumours].
Raida M
Dtsch Med Wochenschr; 2006 Oct; 131(43):2407-10. PubMed ID: 17054057
[No Abstract] [Full Text] [Related]
3. Mutations in tyrosine kinase and tyrosine phosphatase and their relevance to the target therapy in hematologic malignancies.
Zhu N; Xiao H; Wang LM; Fu S; Zhao C; Huang H
Future Oncol; 2015; 11(4):659-73. PubMed ID: 25686120
[TBL] [Abstract][Full Text] [Related]
4. Signal transduction therapy in haematological malignancies: identification and targeting of tyrosine kinases.
Chase A; Cross NC
Clin Sci (Lond); 2006 Oct; 111(4):233-49. PubMed ID: 16961463
[TBL] [Abstract][Full Text] [Related]
5. [Protein tyrosine kinase inhibitors in cancer therapy].
Boutayeb S; Zakkouri FZ; Aitelhaj M; Mesmoudi M; Boutayeb A; Boutayeb W; Mrabti H; Errihani H
Pathol Biol (Paris); 2012 Aug; 60(4):229-33. PubMed ID: 22743095
[TBL] [Abstract][Full Text] [Related]
6. [Hematologic malignancies /pediatric malignancies-current status of molecular target therapy for hematologic cancer].
Usui N
Gan To Kagaku Ryoho; 2010 May; 37(5):805. PubMed ID: 20524247
[No Abstract] [Full Text] [Related]
7. [Hematologic malignancies/pediatric malignancies].
Usui N
Gan To Kagaku Ryoho; 2012 May; 39(5):731. PubMed ID: 22701898
[No Abstract] [Full Text] [Related]
8. [Limitations in application of imatinib in hematologic malignancies: are there new principal solutions?].
Rukavitsyn OA; Pop VP
Ter Arkh; 2008; 80(7):80-4. PubMed ID: 18763606
[No Abstract] [Full Text] [Related]
9. Signal transduction inhibitors (STI571): molecularly targeted therapy.
Corujo Y; Cáceres W
P R Health Sci J; 2002 Sep; 21(3):203-5. PubMed ID: 12243110
[TBL] [Abstract][Full Text] [Related]
10. EPHA3 as a novel therapeutic target in the hematological malignancies.
Keane N; Freeman C; Swords R; Giles FJ
Expert Rev Hematol; 2012 Jun; 5(3):325-40. PubMed ID: 22780212
[TBL] [Abstract][Full Text] [Related]
11. [A role of new molecular-target drugs for hematologic malignancies].
Usui N
Gan To Kagaku Ryoho; 2015 May; 42(5):548-9. PubMed ID: 26054087
[No Abstract] [Full Text] [Related]
12. [Trends in development of molecular targeted therapy for hematological neoplasms].
Nagai T
Rinsho Ketsueki; 2012 Oct; 53(10):1768-75. PubMed ID: 23037750
[No Abstract] [Full Text] [Related]
13. Phase II, open-label study evaluating the activity of imatinib in treating life-threatening malignancies known to be associated with imatinib-sensitive tyrosine kinases.
Heinrich MC; Joensuu H; Demetri GD; Corless CL; Apperley J; Fletcher JA; Soulieres D; Dirnhofer S; Harlow A; Town A; McKinley A; Supple SG; Seymour J; Di Scala L; van Oosterom A; Herrmann R; Nikolova Z; McArthur AG;
Clin Cancer Res; 2008 May; 14(9):2717-25. PubMed ID: 18451237
[TBL] [Abstract][Full Text] [Related]
14. [Targeted therapy in hematologic neoplasia: overview].
Tauchi T; Ohyashiki K
Nihon Rinsho; 2007 Jan; 65 Suppl 1():395-8. PubMed ID: 17474436
[No Abstract] [Full Text] [Related]
15. Novel targeted agents for the treatment of advanced breast cancer.
de la Vega M; Díaz-Cantón E; Alvarez RH
Future Med Chem; 2012 May; 4(7):893-914. PubMed ID: 22571614
[TBL] [Abstract][Full Text] [Related]
16. [mTOR complexes -- molecular spiders in molecular networks].
Kopper L; Tímár J
Magy Onkol; 2011 Nov; 55(4):287-94. PubMed ID: 22128312
[TBL] [Abstract][Full Text] [Related]
17. Modulation of cellular signaling pathways: prospects for targeted therapy in hematological malignancies.
Ravandi F; Talpaz M; Estrov Z
Clin Cancer Res; 2003 Feb; 9(2):535-50. PubMed ID: 12576416
[TBL] [Abstract][Full Text] [Related]
18. Emerging targets for hematological malignancies.
Cilloni D; Frassoni F; Saglio G
Curr Opin Drug Discov Devel; 2010 Sep; 13(5):548-58. PubMed ID: 20812146
[TBL] [Abstract][Full Text] [Related]
19. Signal-transduction inhibitors in renal cell carcinoma.
Vogelzang NJ; Sternberg CN
BJU Int; 2007 May; 99(5 Pt B):1289-95. PubMed ID: 17441926
[No Abstract] [Full Text] [Related]
20. [Chemotherapy in elderly patients with hematological malignancies].
Ohnishi K
Gan To Kagaku Ryoho; 2011 Oct; 38(10):1586-90. PubMed ID: 21996952
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]